Time series modeling of cell cycle exit identifies Brd4 dependent regulation of cerebellar neurogenesis.
Clara PenasMarie E MaloofVasileios StathiasJun LongSze Kiat TanJose MierYin FangCamilo ValdesJezabel Rodriguez-BlancoCheng-Ming ChiangDavid J RobbinsDaniel J LieblJae K LeeMary E HattenJennifer ClarkeNagi G AyadPublished in: Nature communications (2019)
Cerebellar neuronal progenitors undergo a series of divisions before irreversibly exiting the cell cycle and differentiating into neurons. Dysfunction of this process underlies many neurological diseases including ataxia and the most common pediatric brain tumor, medulloblastoma. To better define the pathways controlling the most abundant neuronal cells in the mammalian cerebellum, cerebellar granule cell progenitors (GCPs), we performed RNA-sequencing of GCPs exiting the cell cycle. Time-series modeling of GCP cell cycle exit identified downregulation of activity of the epigenetic reader protein Brd4. Brd4 binding to the Gli1 locus is controlled by Casein Kinase 1δ (CK1 δ)-dependent phosphorylation during GCP proliferation, and decreases during GCP cell cycle exit. Importantly, conditional deletion of Brd4 in vivo in the developing cerebellum induces cerebellar morphological deficits and ataxia. These studies define an essential role for Brd4 in cerebellar granule cell neurogenesis and are critical for designing clinical trials utilizing Brd4 inhibitors in neurological indications.
Keyphrases
- cell cycle
- cell proliferation
- single cell
- cerebral ischemia
- clinical trial
- protein kinase
- cell therapy
- signaling pathway
- induced apoptosis
- dna methylation
- early onset
- gene expression
- traumatic brain injury
- genome wide
- magnetic resonance imaging
- subarachnoid hemorrhage
- young adults
- blood brain barrier
- endoplasmic reticulum stress
- cell cycle arrest
- amino acid